Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


09.10.2017

1 Am J Clin Pathol
1 Am J Obstet Gynecol
1 BMC Cancer
1 Br J Cancer
1 Cancer Lett
1 Cancer Res
1 Clin Cancer Res
1 Gynecol Oncol
1 Int J Cancer
1 Nat Med
2 Obstet Gynecol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. LI Z, Roth R, Rock JB, Lehman A, et al
    Dual Immunostain With SATB2 and CK20 Differentiates Appendiceal Mucinous Neoplasms From Ovarian Mucinous Neoplasms.
    Am J Clin Pathol. 2017;147:484-491.
    PubMed     Text format     Abstract available


    Am J Obstet Gynecol

  2. MARGOLIS B, Chen L, Accordino MK, Hillyer GC, et al
    Trends in End of Life Care and Healthcare Spending in Women with Uterine Cancer.
    Am J Obstet Gynecol. 2017 Jul 11. pii: S0002-9378(17)30848.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. WHICKER ME, Lin ZP, Hanna R, Sartorelli AC, et al
    MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.
    BMC Cancer. 2016;16:550.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. GAYARRE J, Martin-Gimeno P, Osorio A, Paumard B, et al
    Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.
    Br J Cancer. 2017;117:1048-1062.
    PubMed     Text format     Abstract available


    Cancer Lett

  5. LOUGHRAN EA, Phan RC, Leonard AK, Tarwater L, et al
    Multiparity Activates Interferon Pathways in Peritoneal Adipose Tissue and Decreases Susceptibility to Ovarian Cancer Metastasis in a Murine Allograft Model.
    Cancer Lett. 2017 Sep 27. pii: S0304-3835(17)30581.
    PubMed     Text format     Abstract available


    Cancer Res

  6. YIN X, Jing Y, Cai MC, Ma P, et al
    Clonality, heterogeneity and evolution of synchronous bilateral ovarian cancer.
    Cancer Res. 2017 Sep 28. pii: canres.1461.2017.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. KREUZINGER C, Geroldinger A, Smeets D, Braicu EI, et al
    A complex network of tumor microenvironment in human high grade serous ovarian cancer.
    Clin Cancer Res. 2017 Oct 2. pii: clincanres.1159.2017.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  8. TORRES D, Kumar A, Wallace SK, Bakkum-Gamez JN, et al
    Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer.
    Gynecol Oncol. 2017 Sep 27. pii: S0090-8258(17)31345.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. JAREID M, Licaj I, Olsen KS, Lund E, et al
    Does an epidemiological comparison support a common cellular lineage for similar subtypes of postmenopausal uterine and ovarian carcinoma? The Norwegian Women and Cancer Study.
    Int J Cancer. 2017 Jun 8. doi: 10.1002/ijc.30826.
    PubMed     Text format     Abstract available


    Nat Med

  10. JANOUSKOVA H, El Tekle G, Bellini E, Udeshi ND, et al
    Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
    Nat Med. 2017;23:1046-1054.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  11. DILLEY SE, Straughn JM Jr, Leath CA 3rd
    The Evolution of and Evidence for Opportunistic Salpingectomy.
    Obstet Gynecol. 2017;130:814-824.
    PubMed     Text format     Abstract available

  12. VISSER NCM, Reijnen C, Massuger LFAG, Nagtegaal ID, et al
    Accuracy of Endometrial Sampling in Endometrial Carcinoma: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002261.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: